-

Thermo Fisher Scientific’s PPD Clinical Research Business Earns Honor for Employee Development Driving Customer Success

WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific’s PPD clinical research business has been named a winner in Training magazine’s 2022 Training APEX Awards, recognizing its robust enterprise learning programs designed to grow employees’ skills and drive customers’ success.

As part of Thermo Fisher’s commitment to talent development, the PPD clinical research business designs, develops and deploys a wide range of employee learning and performance programs, providing ongoing training and development that engages employees for optimal performance, leverages technology, develops staff and measures outcomes.

“We are honored to win this award for the 11th consecutive year from the highly regarded team at Training magazine,” said Jay Dixon, senior vice president, quality and enterprise learning, clinical research, Thermo Fisher Scientific. “Our learning programs proactively, measurably and efficiently improve performance, readiness and quality across the organization to best serve our customers and help them achieve their clinical research goals.”

Training magazine’s Training APEX Awards were recently rebranded from the Training Top 100. The awards honor each winner’s journey to attain peak performance in employee training and development and organizational success. The awards assessment team evaluated the scope of each organization’s learning program, including budget, reimbursement, infrastructure, evaluation, human resources and metrics.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Contacts

Media Contact Information:
Nadine Maeser
Clinical Research, Thermo Fisher Scientific
Phone: 910-558-4779
Email: nadine.maeser@ppd.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Summary
Thermo Fisher Scientific’s PPD clinical research business has been recognized for its robust enterprise learning programs
Release Versions

Contacts

Media Contact Information:
Nadine Maeser
Clinical Research, Thermo Fisher Scientific
Phone: 910-558-4779
Email: nadine.maeser@ppd.com

More News From Thermo Fisher

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h...

Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n...

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish...
Back to Newsroom